StockData
Sight Sciences, Inc. logo

Sight Sciences, Inc. (SGHT) stock

SGHTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30164% above fair value
$10.77+0.28 (+2.67%)

Close on Nov 18, 2026Market cap $593.30MP/E –Yield –

Sight Sciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Sight Sciences's total debt was $50.91M at Jun 30, 2026. For fiscal 2025 it was $40.30M, up 2.4% from the year before. The highest annual figure on record is $40.30M in fiscal 2025.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$40.30M+2.4%
FY2024Dec 31, 2024$39.36M+16.0%
FY2023Dec 31, 2023$33.93M+1.8%
FY2022Dec 31, 2022$33.31M+2.0%
FY2021Dec 31, 2021$32.66M+2.2%
FY2020Dec 31, 2020$31.96M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$50.91M+27.8%
Q1 FY2026Mar 31, 2026$44.33M+12.0%
Q4 FY2025Dec 31, 2025$40.30M+2.4%
Q3 FY2025Sep 30, 2025$40.07M+17.3%
Q2 FY2025Jun 30, 2025$39.82M+17.9%
Q1 FY2025Mar 31, 2025$39.58M+17.5%
Q4 FY2024Dec 31, 2024$39.36M+16.0%
Q3 FY2024Sep 30, 2024$34.15M+1.1%
Q2 FY2024Jun 30, 2024$33.77M+0.5%
Q1 FY2024Mar 31, 2024$33.70M+0.7%
Q4 FY2023Dec 31, 2023$33.93M+1.8%
Q3 FY2023Sep 30, 2023$33.77M+1.8%
Q2 FY2023Jun 30, 2023$33.61M+1.9%
Q1 FY2023Mar 31, 2023$33.46M+2.0%
Q4 FY2022Dec 31, 2022$33.31M+2.0%
Q3 FY2022Sep 30, 2022$33.16M+2.1%
Q2 FY2022Jun 30, 2022$32.98M+2.1%
Q1 FY2022Mar 31, 2022$32.82M+2.7%
Q4 FY2021Dec 31, 2021$32.66M–
Q3 FY2021Sep 30, 2021$32.49M–
Q2 FY2021Jun 30, 2021$32.30M–
Q4 FY2020Dec 31, 2020$31.96M–

More Sight Sciences figures

See a number that looks wrong?